To top
Unit
ANA-MARIA LENNON DUMENIL / OLIVIER LANTZ
Immunity and Cancer (U932)

Created in 2005, the INSERM U932 Unit is composed of 10 teams, spread over two buildings (Hôpital Curie and Constant-Burg building, rue Lhomond), with a total of about 120 people.

 

Key figures
334
publication since 2017
11
ERC since 2008
3
start-ups
Key publications
All publications
News
All news
Scientific events
23 Sep
2024
Seminar
11h-23h
Why immunologists have no other choice but to do conceptual & theoretical immunology
In this talk, I argue that immunologists who do not think conceptually and theoretically are very unlikely to make useful contributions to their own field.
In a first part, I make three points. First, theories have been crucial in immunology since its inception at the end of the 19th century. Second, theories guide what we think and what we do, experimentally an
16 Sep
2024
Seminar Immunology series
11h-23h
When Nuance Matters: The lesser known side of PD1 signaling
The inhibitory immunoreceptor PD1 is a major cancer immunotherapy target. Anti-PD1 blockade antibodies have become the standard of care for cancer patients, but the low response rate and associated immune related side effects necessitate a better understanding of PD1 mechanism. Best known to be expressed by T cells, PD1 transduces inhibitory signals to attenuate T cell response upon binding to its
10 Sep
2024
Seminar
14h-23h
“B cell memory in barrier tissues” - " From the bench to the bedside: cancer immunotherapy with soluble T cell receptors"
B cell memory in barrier tissues

During infection, the immune system unleashes protective responses to fight against the pathogen while also establishes a memory compartment that will provide protection in case of a subsequent pathogen encounters. The B cell memory compartment is composed of two layers: long-lived plasma cells (LLPCs) and memory B cells (MBCs). LLPCs mainly migrate to the bone
10 Jun
2024
Seminar
11h-23h
Functional and molecular characterization of cancer-derived extracellular vesicles
Cancer-derived extracellular vesicles have been demonstrated to play a crucial role in cancer biology. Our team is particularly interested in cancer EV heterogeneity and we have been studying a particular population of extracellular vesicles, known as large oncosomes. These EVs are released by aggressive cancer cells that exhibit cell plasticity and have acquired metastatic abilities.  I will
All scientific events
Job offers
No job offers available.
All job offers